Naomi Laing

Naomi Laing has extensive experience in the pharmaceutical and biotechnology industry. Naomi is currently working as the VP of Clinical Development at F-star Therapeutics, Inc. Prior to this, they held the position of Senior Director of Early Clinical Development Oncology at Bristol Myers Squibb, where they demonstrated strong leadership and a passion for personalized medicine and patient advocacy. Naomi also served as an Oncology Clinical Program Lead at Bristol Myers Squibb.

Naomi's earlier experience includes roles at AstraZeneca and AstraZeneca R&D. At AstraZeneca, they held the positions of Senior Global Clinical Project Scientist and Principal Medical Scientist, working on late-stage immuno-oncology assets. Naomi was responsible for developing external collaborations and shaping ongoing partnerships with other pharmaceutical companies. At AstraZeneca R&D, they worked as a Principal Translational Scientist, contributing to drug development strategies in oncology and leading multidisciplinary translational teams.

Prior to their time at AstraZeneca, Naomi worked at Bristol-Myers Squibb as a Senior Research Investigator, conducting research in the biologics and small molecule discovery field. Naomi also has experience at the Fox Chase Cancer Center, where they worked as a Post-Doctoral Fellow and Staff Scientist, specializing in molecular pharmacology and drug resistance mechanisms.

Overall, Naomi Laing brings a wealth of experience and expertise in clinical development, oncology research, collaboration strategies, and translational science to their current role.

Naomi Laing has a Bachelor of Science degree in Biochemistry and Nutrition from the University of Guelph. Naomi also holds a PhD in Biochemistry from McMaster University.